catalpol has been researched along with Acute Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiang, Y; Zhang, M | 1 |
| Bi, R; Huo, X; Liu, K; Liu, Z; Ma, X; Meng, Q; Sun, H; Sun, P; Wang, C; Wu, J; Zhang, J | 1 |
2 other study(ies) available for catalpol and Acute Kidney Failure
| Article | Year |
|---|---|
Catalpol ameliorates inflammation and oxidative stress via regulating Sirt1 and activating Nrf2/HO-1 signaling against acute kidney injury.
Topics: Acute Kidney Injury; Animals; Inflammation; Interleukin-6; Lipopolysaccharides; Mice; NF-E2-Related Factor 2; Oxidative Stress; Sepsis; Sirtuin 1; Tumor Necrosis Factor-alpha | 2023 |
Catalpol alleviates adriamycin-induced nephropathy by activating the SIRT1 signalling pathway in vivo and in vitro.
Topics: Acute Kidney Injury; Administration, Oral; Animals; Apoptosis; Cell Survival; Cells, Cultured; Doxorubicin; Iridoid Glucosides; Kidney Diseases; Male; Mice; Mice, Inbred Strains; Protective Agents; Rehmannia; Signal Transduction; Sirtuin 1 | 2019 |